Antifungal activity of genistein 4',7-dirhamnoside and genistein 7-rhamnoside that are produced by kitasatospora kifunensis mjm-134
KR20060010370A
N ??substituted ??sulfamoylbenzoic acid derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
KR20050046466A
Novel antifungal antibiotic which is produced by kitasatosporia kifunense mjm-134
KR20050022823A
A novel macrolides, penthromodin which inhibits blood coagulation by controlling prothrombin activity
KR20050022824A
antithrombotic substance WW2006 from Sterptomyces sp.
KR20040104823A
4-[4-(4-Morpholino)anilino]pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
KR20040104824A
2-[2-(4-Morpholino)ethylamino]pyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
KR20040092305A
Kit for detection of hybrid aminoglycoside with α-hydroxy-γ-aminobutyryl moeity or α-hydroxy-γ-aminobutyryl propionyl moeity and method for selection of transformed microorganism to produce the said hybrid aminoglycoside
KR20040046614A
BCAF-202 to secrete antibiotics against Cryptococcus neoformans and antibiotics thereof
KR20040033099A
6-Methylpyridine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20040033100A
2-Methoxy-1,3,5-triazine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030096980A
Food grade vector comprising PstⅠ-SpeⅠ fragment of pMMH1 plasmid derived from wild-type Bacillis
KR20030090335A
3,4,5-Trifluoropyridine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030090334A
2-[2-(3-Indolyl)ethylamino]pyridine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030079396A
4-(4-Substituted-anilino)pyrimidine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030079394A
2-(Heterocyclic-alkylamino)pyridine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030079395A
6-(4-Substituted-anilino)pyrimidine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030079392A
2-(4-Substituted-anilino)pyridine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030079393A
2-(2-Substituted-anilino)pyridine derivatives, its preparation and antiviral pharmaceutical composition comprising the same
KR20030075638A
The screening method of priming inhibitor for hepatitis B virus
